Laurus Labs Holds a Strong Trend Above the Cloud

is benefiting from a much stronger phase for select pharmaceutical and contract-manufacturing names, where API recovery, higher utilisation, custom synthesis opportunities and improving operating leverage can create a powerful earnings tailwind when the cycle turns. The chart reflects that optimism clearly. Price is trading near the upper end of its recent range and remains comfortably above the Ichimoku cloud, while the conversion line and base line continue to stay positively aligned. The forward cloud is also rising, which keeps the underlying trend firmly constructive. What is especially important here is that recent consolidations have occurred above the cloud rather than through it, suggesting that pullbacks are still being absorbed within the larger uptrend. The immediate zone around the recent highs is the first hurdle, and a clean breakout with follow-through can extend the trend further. On the downside, the conversion/base-line region becomes the first dynamic support, with the cloud acting as the deeper trend support. As long as price continues to hold above these levels, the broader structure remains bullish and the chart continues to favour trend continuation over reversal.